In view of the decision taken at the Extraordinary General Meeting on 22 February 2022, the Board of Directors of FRISQ Holding AB has decided to postpone the year-end report for 2021 to be able to complete a possible sale of the subsidiaries.
New date for the report is Wednesday, March 2 at 08.00 CET, 2022.
For further information:
George Thaw, CEO, FRISQ
investor@frisq.se
About FRISQ:
FRISQ is a healthtech company built on the conviction that the quality of the care you get should not be dependent on your ability to navigate a complex system and constantly evolving treatments. The software solution FRISQ Care enables the creation of personalized, digital care plans that facilitate collaboration and secure information sharing between care teams, doctors and patients through the same platform.
Since 2016, FRISQ has been listed on Nasdaq First North Stockholm under the symbol “FRISQ”. FNCA Sweden AB is FRISQ’s Certified Adviser and can be reached via the following contact information: +46 8 528 00 399, info@fnca.se
The publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail.
For more information, please visit: www.frisqholding.se